• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

33.53 -1.20 (-3.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,043,593
Open 32.90
Bid (Size) 33.51 (1)
Ask (Size) 33.75 (3)
Prev. Close 34.73
Today's Range 32.76 - 34.89
52wk Range 18.92 - 81.73
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
Today 4:15 EDT
These stocks have climbed in the triple digits over the past few years. 
Via The Motley Fool
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly?
October 16, 2025
The smaller drugmaker is looking to disrupt a fast-growing market. 
Via The Motley Fool

Performance

YTD
-18.4%
-18.4%
1 Month
+41.6%
+41.6%
3 Month
+4.6%
+4.6%
6 Month
+40.1%
+40.1%
1 Year
-49.1%
-49.1%

More News

Read More
Down 44%, Should You Buy the Dip on Viking Therapeutics?
October 13, 2025
Via The Motley Fool
4 Healthcare Stocks to Buy Now
October 12, 2025
Via The Motley Fool
Topics Artificial Intelligence
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
October 06, 2025
Via Stocktwits
Why Shares in Viking Therapeutics Surged This Week
October 09, 2025
Via The Motley Fool
The Best Stocks to Invest $1,000 in Right Now
October 05, 2025
Via The Motley Fool
Topics Artificial Intelligence
Why This Beaten-Down GLP-1 Stock Could Be a Steal
September 30, 2025
Via The Motley Fool
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
September 25, 2025
Via The Motley Fool
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
September 22, 2025
Via Stocktwits
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
September 22, 2025
Via MarketMinute
Topics Economy Intellectual Property
6 Health Care Stocks Whale Activity In Today's Session
September 22, 2025
Via Benzinga
Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months
September 19, 2025
Via The Motley Fool
Topics Bankruptcy
Biotech Breakouts: 3 Stocks With Massive Upside Potential
September 17, 2025
Via MarketBeat
Novo Nordisk Faces Headwinds: Competitive Pressures and Compounded Drugs Force Lowered Outlook
September 15, 2025
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback
September 11, 2025
Via The Motley Fool
Topics ETFs
Peering Into Viking Therapeutics's Recent Short Interest
September 09, 2025
Via Benzinga
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
September 07, 2025
Via The Motley Fool
Jim Cramer Expects Palantir To Reach New All-Time High
September 05, 2025
Via Benzinga
Down 34%, Should You Buy the Dip on Viking Therapeutics?
September 05, 2025
Via The Motley Fool
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years
September 04, 2025
Via The Motley Fool
The Problem With Weight Loss Stocks
September 03, 2025
Via The Motley Fool
Topics Economy
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
August 29, 2025
Via The Motley Fool
Why Viking Therapeutics Stock Popped Nearly 4% Today
August 28, 2025
Via The Motley Fool
Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)
August 27, 2025
Via The Motley Fool
Topics Economy World Trade

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 33.53
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 10/17/25 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.34B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap